OKAPI SCIENCES
Okapi Sciences NV, a Belgium-based company with a proprietary pet therapeutics antiviral platform and five clinical/development stage candidates for treating important viral diseases. The strategic acquisition of Okapi further enhances Aratana's leadership position in pet therapeutics by bringing with it a unique combination of individuals, strong relationships with academic institutions, novel technologies and products, and favorable geographic location. Aratana plans to continue to advance the current Okapi pipeline of high value antiviral drugs, including its feline herpes and feline immunodeficiency virus franchises.
OKAPI SCIENCES
Social Links:
Industry:
Biotechnology Clinical Trials Therapeutics
Founded:
2007-01-01
Address:
Heverlee, Vlaams-Brabant, Belgium
Country:
Belgium
Website Url:
http://www.okapi-sciences.com
Total Employee:
11+
Status:
Closed
Contact:
32 1 629 97 26
Total Funding:
10.79 M USD
Technology used in webpage:
Amazon Amazon Oregon Region
Founder
Investors List
The Institute for the Promotion of Innovation by Science and Technology in Flanders
The Institute for the Promotion of Innovation by Science and Technology in Flanders investment in Grant - Okapi Sciences
KBC
KBC investment in Series A - Okapi Sciences
Agri Investment Fund
Agri Investment Fund investment in Series A - Okapi Sciences
Spinventure
Spinventure investment in Series A - Okapi Sciences
Vinnof
Vinnof investment in Series A - Okapi Sciences
Thuja Capital
Thuja Capital investment in Series A - Okapi Sciences
Thuja Capital
Thuja Capital investment in Venture Round - Okapi Sciences
Official Site Inspections
http://www.okapi-sciences.com
Unable to get host informations!!!
